Journal article

High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: From "orphan drug" to a standard-of-care?

C Van Der Weyden, HM Prince

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2016

DOI: 10.3109/10428194.2015.1058937

University of Melbourne Researchers

Citation metrics

1Scopus
1Web of Science
8Dimensions

Keywords

Busulfan
Chemotherapy
Life Sciences & Biomedicine
Stem-Cell Transplantation
Hematology
Lymphatic Research
Primary Cns Lymphoma
3211 Oncology and Carcinogenesis
Science & Technology
Rare Diseases
32 Biomedical and Clinical Sciences
Cancer
Cyclophosphamide
Oncology
Orphan Drug
Neurosciences
Rescue
Recurrent